{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:29Z","timestamp":1786119509545,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/cmr.0b013e32833ab159","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T08:17:41Z","timestamp":1276849061000},"page":"431-434","source":"Crossref","is-referenced-by-count":1,"title":["Her2 overexpression is a rare event in anorectal melanoma"],"prefix":"10.1097","volume":"20","author":[{"given":"Burkhard Maria","family":"Helmke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Zahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Breinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Aulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Andr\u00e9","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1053\/j.gastro.2004.08.051","article-title":"BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level","volume":"127","author":"Helmke","year":"2004","journal-title":"Gastroenterology"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2559.2008.03200.x","article-title":"DMBT1 expression distinguishes anorectal from cutaneous melanoma","volume":"54","author":"Helmke","year":"2009","journal-title":"Histopathology"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008390-200208000-00013","article-title":"Successful palliation of stenosing anorectal melanoma by intratumoral injections with natural interferon-beta","volume":"12","author":"Ulmer","year":"2002","journal-title":"Melanoma Res"},{"key":"R4-10-20210129","first-page":"612","article-title":"Complete remission of the liver metastases of anorectal malignant melanoma with regional chemotherapy: a case report","volume":"47","author":"Koksal","year":"2000","journal-title":"Hepatogastroenterol"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.cmr.0000130874.33504.2f","article-title":"Her2\/neu is not a commonly expressed therapeutic target in melanoma-a large cohort tissue microarray study","volume":"14","author":"Kluger","year":"2004","journal-title":"Melanoma Res"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00432-003-0509-8","article-title":"Immunohistochemical determination of HER-2\/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma","volume":"130","author":"Potti","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jso.10297","article-title":"Absence of HER2 overexpression in metastatic malignant melanoma","volume":"84","author":"Inman","year":"2003","journal-title":"J Surg Oncol"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00008390-200204000-00006","article-title":"Overexpression of HER-2 in thick melanoma","volume":"12","author":"Eliopoulos","year":"2002","journal-title":"Melanoma Res"},{"key":"R9-10-20210129","first-page":"2793","article-title":"No evidence for c-erbB-2 overexpression in cutaneous melanoma","volume":"21","author":"Fink-Puches","year":"2001","journal-title":"Anticancer Res"},{"key":"R10-10-20210129","first-page":"1965","article-title":"Amplification and overexpression of HER-2\/neu are uncommon in advanced stage melanoma","volume":"20","author":"Persons","year":"2000","journal-title":"Anticancer Res"},{"issue":"4","key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.7-suppl_4-31","article-title":"Epidermal growth factor receptor dependence in human tumors: more than just expression?","volume":"7","author":"Arteaga","year":"2002","journal-title":"The Oncologist"},{"key":"R12-10-20210129","first-page":"4067","article-title":"Immunohistochemical determination of HER-2\/neu in malignant melanoma","volume":"23","author":"Potti","year":"2003","journal-title":"Anticancer Res"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","article-title":"Assessment of a Her2 scoring system for gastric cancer: results from a validation study","volume":"52","author":"Hofmann","year":"2008","journal-title":"Histopathology"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00001813-200502000-00012","article-title":"Long-term remission of excessive liver metastases in a breast cancer patient with chronic alcohol abuse using a monotherapy with trastuzumab","volume":"16","author":"Eichbaum","year":"2005","journal-title":"Anticancer Drugs"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1440-0960.1999.00310.x","article-title":"Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridisation","volume":"40","author":"Sparrow","year":"1999","journal-title":"Austral J Dermatol"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1523-1747.ep12616793","article-title":"Increasing epidermal growth factor receptor expression in human melanocytic tumor progression","volume":"99","author":"de Wit","year":"1992","journal-title":"J Invest Dermatol"},{"key":"R17-10-20210129","first-page":"2023","article-title":"Expression of epidermal growth factor receptor: risk factor in uveal melanoma","volume":"41","author":"Hurks","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008390-201010000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:27:41Z","timestamp":1786040861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008390-201010000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32833ab159","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}